hotspot -WSS

hotspot

author：explore 2025-09-27 17:02:10 - browse：32745

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Lilly’s weekly insulin works as well as daily products, new studies show

focus

WSS

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Readout LOUD podcast: Live from the 2023 STAT Summit

STAT Summit: Ending the crisis of Black deaths in the U.S.

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

FDA clears Verve to begin U.S. study of gene

Wikipedia

hotspot

hotspot

Medical records are filled with copy

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Continuity nursing helped my family in our darkest PICU moments

Lilly’s weekly insulin works as well as daily products, new studies show

In age of alternative facts, a scholarly course on calling out crap

Free medical tuition alone isn't enough to close gaps in primary care

In Memoriam: Notable people who died in 2023

The United States must get value

Tori Bowie and the unacceptable rates of Black maternal death

Fertility clinic egg and embryo storage is a disaster

entertainment

Health tech investors get more selective as pandemic boom fades

STAT Readout: Friday, Oct. 20 biotech updates

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Roche acquires Telavant from Roivant, adding experimental IBD treatment

As H5N1 spreads in cows, experts warn against drinking raw milk

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

focus

focus

entertainment

focus